Hypertension among people living with HIV receiving dolutegravir-based antiretroviral therapy in ethiopia: a cross-sectional study

Abstract Recently, dolutegravir (DTG) has been associated with weight gain, dyslipidemia, and hyperglycemia, which in turn raise(s) the risk of hypertension. However, little is known about the burden of hypertension among people living with HIV (PLHIV) taking DTG-based therapy in Ethiopia. This stud...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Mohammed Jemal, Desalegn Abebaw, Yabibal Tsegaye Workineh, Worku Abie Liyew, Tabarak Malik, Adane Adugna
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Nature Portfolio 2025-07-01
Reeks:	Scientific Reports
Onderwerpen:	Hypertension HIV People living with HIV (PLHIV) Dolutegravir (DTG) ART
Online toegang:	https://doi.org/10.1038/s41598-025-06145-z
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!